Posted in | News

Aecon/Dufferin Joint Venture Selected for $261 Million York Viva Bus Rapid Transit Project

Aecon Group Inc. advised today that the Region of York has announced that York RapidLINK Constructors, a 50/50 joint venture comprised of Aecon and Dufferin Construction Company, a division of Holcim (Canada) Inc., has been chosen for a $261 million project to design and build the York Viva Bus Rapid Transit (vivaNext) rapidways along Yonge Street in the Towns of Richmond Hill and Newmarket.

The scope of the project includes widening Yonge Street to accommodate approximately nine kilometres of dedicated rapidway lanes for Viva rapid transit vehicles in the centre of the road, as well as ten new vivastations.

Work will commence in the second quarter of 2014 and is expected to be complete in the fourth quarter of 2018.

"This contract highlights the unmatched multi-disciplinary expertise Aecon brings to the table," said Teri McKibbon, Aecon's President & Chief Operating Officer. "We look forward to working with our partner Dufferin Construction, the Region of York and Metrolinx to deliver a sustainable transportation network."

Aecon Group Inc. is a Canadian leader in construction and infrastructure development providing integrated turnkey services to private and public sector clients. Aecon is pleased to be consistently recognized as one of the Best Employers in Canada.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.